Phytotherapeutical Alternatives for the Treatment of Benign Prostatic Hyperplasia in Obesity
Open Access
- 31 December 2014
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Conference Proceedings Journal
- Vol. 5 (1) , 28-34
Abstract
Phytotherapeutical Alternatives for the Treatment of Benign Prostatic Hyperplasia in ObesityKeywords
This publication has 56 references indexed in Scilit:
- Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostateWorld Journal of Urology, 2013
- High fat-induced obesity associated with insulin-resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostateCell and tissue research, 2012
- Postprandial whole-body glycolysis is similar in insulin-resistant and insulin-sensitive non-diabetic humansDiabetologia, 2011
- An interaction between carotene-15,15′-monooxygenase expression and consumption of a tomato or lycopene-containing diet impacts serum and testicular testosteroneInternational Journal of Cancer, 2011
- A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTSNeurourology and Urodynamics, 2007
- A prospective study of the efficacy of Serenoa repens, Tamsulosin, and Serenoa repens plus Tamsulosin treatment for patients with benign prostate hyperplasiaInternational Urology and Nephrology, 2007
- The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasiaWorld Journal of Urology, 2002
- A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repensUrological Research, 2000
- Pharmacological effects of the lipidosterolic extract ofSerenoa repens (Permixon ) on rat prostate hyperplasia induced by hyperprolactinemia: Comparison with finasterideThe Prostate, 2000
- Spontaneous Hyperplasia of the Ventral Lobe of the Prostate in Aging Genetically Hypertensive RatsJournal of Andrology, 2000